Filing Details
- Accession Number:
- 0000950170-25-027860
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-02-26 16:46:41
- Reporting Period:
- 2025-02-26
- Filing Date:
- 2025-02-26
- Accepted Time:
- 2025-02-26 16:46:41
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1347178 | Vanda Pharmaceuticals Inc. | VNDA | Pharmaceutical Preparations (2834) | 030491827 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1355537 | Hristos Mihael Polymeropoulos | 2200 Pennsylvania Avenue Nw Suite 300E Washington DC 20037 | President And Ceo | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2025-02-26 | 5,000 | $4.75 | 2,336,730 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2025-02-26 | 5,000 | $4.78 | 2,341,730 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |